Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13776
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJayachandran, Aparna-
dc.contributor.authorPrithviraj, Prashanth-
dc.contributor.authorLo, Pu-Han-
dc.contributor.authorWalkiewicz, Marzena-
dc.contributor.authorAnaka, Matthew-
dc.contributor.authorWoods, Briannyn-
dc.contributor.authorBehren, Andreas-
dc.contributor.authorCebon, Jonathan S-
dc.contributor.authorMcKeown, SJ-
dc.date.accessioned2016-05-16T23:31:03Z-
dc.date.accessioned2016-05-16T23:31:15Z-
dc.date.available2016-05-16T23:31:15Z-
dc.date.available2016-05-16T23:31:03Z-
dc.date.issued2016-07-
dc.identifier.citationOncotarget 2016; 7(27): 41186-41202en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/13776-
dc.description.abstractEpithelial-to-mesenchymal transition is a critical process that increases the malignant potential of melanoma by facilitating invasion and dissemination of tumor cells. This study identified genes involved in the regulation of cellular invasion and evaluated whether they can be targeted to inhibit melanoma invasion. We identified Peroxidasin (PXDN), Netrin 4 (NTN4) and GLIS Family Zinc Finger 3 (GLIS3) genes consistently elevated in invasive mesenchymal-like melanoma cells. These genes and proteins were highly expressed in metastatic melanoma tumors, and gene silencing led to reduced melanoma invasion in vitro. Furthermore, migration of PXDN, NTN4 or GLIS3 siRNA transfected melanoma cells was inhibited following transplantation into the embryonic chicken neural tube compared to control siRNA transfected melanoma cells. Our study suggests that PXDN, NTN4 and GLIS3 play a functional role in promoting melanoma cellular invasion, and therapeutic approaches directed toward inhibiting the action of these proteins may reduce the incidence or progression of metastasis in melanoma patients.-
dc.subjectTransplantationen_US
dc.subjectMelanomaen_US
dc.subjectEpithelial-Mesenchymal Transitionen_US
dc.titleIdentifying and targeting determinants of melanoma cellular invasionen_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleOncotargeten_US
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Olivia Newton-John Cancer and Wellness Centre, Heidelberg, Victoria, Australia-
dc.identifier.affiliationLudwig Institute for Cancer Research, Melbourne-Austin Branch, Victoria, Australia-
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Victoria, Australia-
dc.identifier.affiliationSchool of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia -
dc.identifier.affiliationThe University of Queensland School of Medicine and the Gallipoli Medical Research Institute, Greenslopes Private Hospital, Brisbane, Queensland, Australia-
dc.identifier.affiliationDepartment of Anatomy and Neuroscience, University of Melbourne, Victoria, Australia-
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/27172792en_US
dc.identifier.doi10.18632/oncotarget.9227en_US
dc.type.contentTexten_US
dc.type.austinJournal Articleen_US
local.name.researcherCebon, Jonathan S
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

44
checked on Feb 5, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.